Market cap data unavailable. We couldn't positively verify this ticker's market cap is under $500M. Verify independently before trading.
Positron Corporation is a healthcare firm specializing in nuclear medicine, with a core emphasis on cardiac Positron Emission Tomography (PET) imaging services throughout the United States. The company empowers healthcare providers by offering its proprietary Attrius PET scanner, comprehensive clinical and technical support, and flexible financing solutions. These integrated offerings enable medical professionals to precisely diagnose heart conditions, enhance patient health outcomes, and deliver medical care with greater cost-efficiency. Positron Corporation was founded in 1983 and operates from its headquarters in Niagara Falls, New York.
Positron Secures Multiple PET-CT Orders Amid Accelerating Shift to Cardiac PET
Positron announced three new orders for its 64-slice PET-CT systems, each accompanied by multi-year service agreements, from nuclear cardiologists specializing in cardiovascular diagnostics.
The orders underscore the company's commercial momentum as healthcare providers transition from traditional SPECT imaging to cardiac PET.
Management expressed confidence that its technology and value proposition will accelerate adoption as the company prepares for the broader commercial launch of its platform.